MAPK3 and neuroblastoma: Some CAFs originate from MSCs, and research has shown that CAF-MSCs (CAFs with MSC characteristics) from neuroblastoma (NB) enhance tumour engraftment, growth and resistance to etoposide or melphalan via STAT3 and ERK1/2 signalling in vivo [125].